Drug-labels.com Search Menu

Apo-Ticagrelor: Uses, Side Effects and Dosage

Status:
Prescription (Rx) Facts
Strength:
60 mg, 90 mg
Active ingredient:
ATC code:

Patient Medication Information: uses, side effects, how to take - Apo-Ticagrelor

What APO-TICAGRELOR is used for:

APO-TICAGRELOR is used in combination with low dose acetylsalicylic acid (aspirin) in adults to help prevent blood clots and reduce the risk of having or dying from conditions caused by blood clots. This includes:

  • stroke
  • heart attack
  • heart or blood vessel problems.

APO-TICAGRELOR is given to patients who:

  • have had a heart attack or angina (chest pain)
  • have had a heart attack over a year ago and are at high risk of having a heart attack or stroke
  • have coronary artery disease (buildup of plaque in the arteries), type 2 diabetes, no history of a heart attack or stroke, and have previously had a procedure to open a blocked or narrowed heart blood vessel (percutaneous coronary intervention or PCI). This may have included placement of a small tube (stent) to keep the blocked or narrowed blood vessel open. These patients also have a high risk of having a heart attack or stroke.

How APO-TICAGRELOR works:

APO-TICAGRELOR belongs to a group of medicines called antiplatelet agents. Platelets are very small fragments in the blood that clump together during blood clotting.

APO-TICAGRELOR helps prevent this clumping and reduces the risk of blood clots forming.

The ingredients in APO-TICAGRELOR are:

Medicinal ingredients: Ticagrelor

Non-medicinal ingredients: Colloidal silicon dioxide, croscarmellose sodium, isomalt 75:25, magnesium stearate, polyethylene glycol, polyvinyl alcohol, powdered cellulose, red ferric oxide (60 mg only), talc, titanium dioxide and yellow iron oxide (90 mg only).

APO-TICAGRELOR comes in the following dosage forms:

Tablets: 60 mg and 90 mg.

Do not use APO-TICAGRELOR if:

  • you are allergic to ticagrelor or any of the ingredients in APO-TICAGRELOR.
  • you are actively bleeding due to a medical condition, such as bleeding in your stomach or gut from an ulcer or bleeding in your skull or brain.
  • you have a history of bleeding inside your skull or brain.
  • you have liver problems.
  • you are taking the following medicines:

    • ketoconazole, a medicine used to treat fungal infections,
    • clarithromycin, a medicine used to treat bacterial infections,
    • nefazodone, a medicine used to treat depression,
    • ritonavir or atazanavir, medicines used to treat HIV/AIDS.

To help avoid side effects and ensure proper use, talk to your healthcare professional before you take APO-TICAGRELOR. Talk about any health conditions or problems you may have, including if you:

  • have an increased risk of bleeding because of:

    • a recent serious injury
    • your daily activities put you at high risk of having a serious injury
    • recent surgery (including dental procedures)
    • recent bleeding from your stomach or gut (such as a stomach ulcer or colon ‘polyps’)
    • a bleeding disorder
  • have an increased risk of bleeding because you take any of the following:

    • blood thinners such as warfarin
    • medicines that help dissolve blood clots such as streptokinase and alteplase
    • non-steroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen, celecoxib and naproxen
    • high dose acetylsalicylic acid (aspirin)
  • are having surgery (including dental procedures) at any time while taking APO-TICAGRELOR.
  • had a stroke in the past.
  • have a history of slow heartbeat, are taking medicines that slow down your heartbeat or have a condition that puts you at risk of having slow heartbeat episodes.
  • have a history of asthma or other breathing problems.
  • have a history of gout.
  • have been told by a healthcare professional that you have high levels of uric acid in your blood.
  • have kidney problems.

Other warnings you should know about:

Do not stop taking APO-TICAGRELOR without first talking to your healthcare professional. If you stop taking APO-TICAGRELOR, blood clots may form and cause a stroke, heart attack, or other serious complications. This can lead to severe disability or even death.

APO-TICAGRELOR may cause serious side effects, including:

  • Increased levels of uric acid in the blood: This can lead to a disease called gout that causes painful joints. Tell your healthcare professional right away if you experience red, swollen, hot or painful joints.
  • Bradyarrhythmia (slower than normal heart rate related to problems with the control of the heart rhythm): This may happen shortly after taking APO-TICAGRELOR. Your healthcare professional will closely monitor your heart rate during the first few weeks of treatment. Tell your healthcare professional right away if you experience a slow heart rate.
  • Thrombotic Thrombocytopenic Purpura (TTP) (a rare disorder that causes blood clots to form in small blood vessels throughout the body): Rare cases of TTP were reported in patients taking APO-TICAGRELOR. This condition can cause serious complications or even death. Tell your healthcare professional right away if you experience some or all of the following symptoms:

    • fever
    • purplish spots on the skin or in the mouth (purpura)
    • yellowing of the skin or eyes (jaundice)
    • unexplained extreme tiredness or confusion
  • Dyspnea (shortness of breath): This includes shortness of breath when you are at rest, active and during sleep. It usually stops as you continue taking APO-TICAGRELOR. Tell your healthcare professional right away if you experience shortness of breath, especially if it gets worse or does not seem to go away.

See the Serious side effects and what to do about them table, below, for more information on these and other serious side effects.

Irregular breathing: The following side effects were reported in a small number of patients while taking APO-TICAGRELOR (frequency cannot be estimated from the available data):

  • Central sleep apnea (disorder in which your breathing repeatedly stops and starts during sleep, and may occur in patients with heart disease, stroke or other causes)
  • Cheyne-Stokes respiration (a rare abnormal breathing pattern that involves a period of fast, shallow breathing followed by slow heavier breathing and moments without any breath at all)

Tell your healthcare professional if you develop any of the irregular breathing side effects above. Your healthcare professional will decide if you need further evaluation.

Surgery:

  • If you should see another healthcare professional or a dentist, you should inform them that you are taking APO-TICAGRELOR.
  • Tell your healthcare professional if you are going to have any surgeries, including dental procedures, while taking APO-TICAGRELOR. There is an increased risk of bleeding if you take APO-TICAGRELOR during these procedures. It can be life threatening.
  • Your healthcare professional may ask you to stop taking APO-TICAGRELOR before the surgery, and to resume taking APO-TICAGRELOR after the procedure. It is important that you take APO-TICAGRELOR before and after the procedure exactly at the times the healthcare professional has instructed.

Driving and using machines: APO-TICAGRELOR can cause dizziness, confusion, vertigo and fainting. You should not drive or use machines until you know how APO-TICAGRELOR affects you.

Pregnancy:

  • It is not known if APO-TICAGRELOR can cause harm to your baby during pregnancy. Therefore, APO-TICAGRELOR should not be used while you are pregnant.
  • Your healthcare professional may recommend that you use a highly effective birth control method while taking APO-TICAGRELOR.
  • Talk to your healthcare professional right away if you discover that you are pregnant while taking APO-TICAGRELOR.

Breastfeeding: It is not known if ticagrelor can pass into breast milk. Therefore, APO-TICAGRELOR should not be used during breastfeeding. Talk to your healthcare professional about ways to feed your baby if you were planning to breastfeed while taking APO-TICAGRELOR.

Check-ups and testing: If you have coronary artery disease and type 2 diabetes, your healthcare professional will regularly monitor you to make sure APO-TICAGRELOR is right for you. Your healthcare professional will discuss any risks and ways to prevent possible side effects while you are taking APO-TICAGRELOR.

Tell your healthcare professional about all the medicines you take, including any drugs, vitamins, minerals, natural supplements or alternative medicines.

Serious drug interactions:

Serious drug interactions with APO-TICAGRELOR include:

  • ketoconazole, a medicine used to treat fungal infections,
  • clarithromycin, a medicine used to treat bacterial infections,
  • nefazodone, a medicine used to treat depression,
  • ritonavir or atazanavir, medicines used to treat HIV/AIDS.

Taking APO-TICAGRELOR with these medicines may cause serious drug interactions. Ask your healthcare professional if you are unsure.

The following may also interact with APO-TICAGRELOR:

  • blood thinners such as warfarin
  • medicines that help dissolve blood clots such as streptokinase and alteplase
  • non-steroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen, celecoxib and naproxen
  • high dose (greater than 150 mg daily) acetylsalicylic acid (aspirin)
  • rifampin, a medicine used to treat bacterial infections
  • medicines used to prevent epilepsy or seizures such as carbamazepine, phenytoin, or phenobarbital
  • dexamethasone, a medicine used to relieve inflammation and treat other conditions
  • cyclosporine, a medicine used to suppress your immune system
  • rosuvastatin, simvastatin, or lovastatin, medicines used to treat high blood cholesterol
  • digoxin, a medicine used to treat various heart conditions
  • morphine, a medicine used to relieve pain

Know the medicines you take. Ask your healthcare professional if you are not sure whether your medicine is one of the medicines listed above. Keep a list of them to show your healthcare professional or pharmacist when you get a new medicine.

While you are on APO-TICAGRELOR it is important that you do not take any medicine other than that prescribed by your healthcare professional.

How to take APO-TICAGRELOR:

  • Take APO-TICAGRELOR with or without food.

  • Take APO-TICAGRELOR exactly as your healthcare professional tells you.
  • Swallow the APO-TICAGRELOR tablet whole with some water.
  • Take one in the morning and one in the evening at around the same time every day.
  • Your healthcare professional will usually also tell you to take low dose acetylsalicylic acid (aspirin) (between 75 mg and 150 mg) once a day.
  • Your healthcare professional will tell you how long you should take APO-TICAGRELOR. Do not stop taking APO-TICAGRELOR without first talking to your healthcare

    • professional.

If you have trouble swallowing the tablet(s), follow the steps below to crush the APO-TICAGRELOR tablet(s). This will help make sure that all of the crushed tablet(s) will be transferred to the drinking glass.

  • use a mortar and pestle or a similar device to crush the tablet(s)
  • add a small amount of water (100 mL) to the mortar and pestle/device and stir for 1 minute
  • transfer the water and crushed tablet mixture to a drinking glass
  • add more water (100 mL) to the mortar and pestle/device and stir for 30 seconds
  • transfer the water and crushed tablet mixture to the same drinking glass
  • stir the contents of the drinking glass and drink it right away

How to use the blister (6x10 tablets) pack

APO-TICAGRELOR comes in a blister pack with the time of day printed on the back of the blister (to help you keep track of your doses).

There are 10 tablets in each blister: 10 are labelled with the time of day (AM or PM). All 10 tablets are exactly the same. Use the following dosing instructions:

First dose for each blister pack:

  • Start with the tablet that is labelled “AM” or “PM”,

Second dose (one tablet) from the blister pack:

  • Take your second tablet (about 12 hours later) that matches the time of day (AM or PM),

Next doses from the blister pack:

  • Continue to take one tablet alternating morning (AM) and evening (PM), until they are all finished.

Usual dose:

Adults – 90 mg

If you had a recent heart attack or angina (chest pain), a healthcare professional will give you 180 mg (two 90 mg tablets) of APO-TICAGRELOR for your first dose. After this first dose, the usual dose is one 90 mg tablet twice a day.

After one year your healthcare professional may continue your treatment with a lower dose of APO-TICAGRELOR.

Adults – 60 mg

The usual dose is one 60 mg tablet twice a day if you:

  • had a heart attack over a year ago, or
  • have coronary heart disease, type 2 diabetes, no previous history of a heart attack or stroke, and have had a procedure to open a blocked or narrowed heart blood vessel (PCI).

Overdose:

Symptoms of an overdose include:

  • excessive bleeding
  • shortness of breath
  • pauses in heartbeat

If you think you, or a person you are caring for, have taken too much APO-TICAGRELOR, contact a healthcare professional, hospital emergency department, regional poison control centre or Health Canada’s toll-free number, 1-844 POISON-X (1-844-764-7669) immediately, even if there are no signs or symptoms.

Missed dose:

If you forget or miss a dose of APO-TICAGRELOR, skip the missed dose and take the next dose as scheduled. Do not double the dose to make up for the missed dose.

Possible side effects from using APO-TICAGRELOR:

These are not all the possible side effects you may have when taking APO-TICAGRELOR. If you experience any side effects not listed here, tell your healthcare professional.

The most common side effects of APO-TICAGRELOR are:

  • Headache
  • Feeling dizzy or like the room is spinning
  • Abdominal pain, constipation, diarrhea or indigestion (heartburn)
  • Nausea or vomiting
  • Itching
  • A tingling feeling
  • Inflamed stomach lining
  • Fatigue, muscle weakness
  • Anxiety
  • Sore throat or runny nose
  • Cough
  • Feeling dizzy or lightheaded, or having blurred vision (signs of low blood pressure)
  • Bleeding gums

APO-TICAGRELOR affects blood clotting, so most side effects are related to bleeding. Bleeding may occur in any part of the body. Some bleeding is common (like bruising and nose bleeds). Severe bleeding is uncommon, but can be life threatening (see the Serious side effects and what to do about them table below).

APO-TICAGRELOR can cause abnormal blood test results. Your healthcare professional will decide when to perform blood tests and will interpret the results.

Serious side effects and what to do about them

Frequency/Side Effect/SymptomTalk to your healthcare professionalStop taking this drug and get immediate medical help
Frequency/Side Effect/SymptomTalk to your healthcare professionalStop taking this drug and get immediate medical help
Frequency/Side Effect/SymptomTalk to your healthcare professionalStop taking this drug and get immediate medical help
Only if severeIn all cases
Only if severeIn all cases
Only if severeIn all cases
Very common
Bleeding caused by blood disorder
Dyspnea (shortness of breath)
Increased levels of uric acid in the blood: possible red, swollen, hot and painful joint (signs of gout)
Common
Bleeding: blood in your urine (pink, red or brown urine) or stools (red or black stools – looks like tar), vomiting blood, coughing up blood, nosebleed, bruising or bleeding into the skin, bleeding more than normal after surgery or cuts or wounds, bleeding that is severe or that lasts a long time
Chest pain
Heart problems: rapid, slow or irregular heartbeat or increased fatigue, swelling of legs and feet and shortness of breath

Signs of a stroke including:

  • sudden numbness or weakness of your arm, leg or face, especially if only on one side of the body.
  • sudden confusion, difficulty speaking or understanding others.
  • sudden difficulty in walking or loss of balance or coordination.
  • suddenly feeling dizzy or sudden severe headache with no known cause.
Sleeplessness
Swelling of your legs or ankles
Syncope (fainting): temporary loss of consciousness due to sudden drop in blood flow to the brain
Uncommon
Anemia (decreased number of red blood cells): shortness of breath, paleness, weakness
Bleeding: blood in your eye, ear or tumour, heavier vaginal bleeding or bleeding at different times than normal menstrual bleeding, bleeding into joints and muscles causing painful swelling, internal bleeding that may cause dizziness or light-headedness
Confusion
Intracranial hemorrhage (bleeding in the skull or brain): sudden, severe headache, confusion, nausea and vomiting, seizures, loss of consciousness
Kidney stones: pain when urinating, severe pain in the side and back, below the ribs
Lung fibrosis (scarring of the lungs): shortness of breath, dry cough, fatigue, aching muscles and joints, unexplained weight loss
Pulmonary hypertension (high blood pressure in the lungs): shortness of breath, dizziness, fatigue, racing pulse
Unknown
Allergic reaction: rash, hives, itching, swelling of the face, lips, tongue or throat, difficulty swallowing or breathing
Bradyarrhythmia (slower than normal heart rate related to problems with the control of heart rhythm): fainting or near-fainting, light-headedness, weakness, fatigue, shortness of breath, confusion or memory problems
Rash
Thrombotic Thrombocytopenic Purpura (TTP) (a rare disorder that causes blood clots to form in small blood vessels throughout the body):
fever and purplish spots (called purpura) on the skin or in the mouth, with or without yellowing of the skin or eyes (jaundice), unexplained extreme tiredness or confusion

If you have a troublesome symptom or side effect that is not listed here or becomes bad enough to interfere with your daily activities, tell your healthcare professional.

Reporting Side Effects

You can report any suspected side effects associated with the use of health products to Health Canada by:

  • Visiting the Web page on Adverse Reaction Reporting (canada.ca/drug-device-reporting) for information on how to report online, by mail or by fax; or
  • Calling toll-free at 1-866-234-2345.

NOTE: Contact your healthcare professional if you need information about how to manage your side effects. The Canada Vigilance Program does not provide medical advice.

Storage:

  • Store at room temperature 15°C - 30°C.
  • Keep APO-TICAGRELOR and all medicines out of the reach and sight of children.
  • The expiry date of this medicine is printed on the package label. Do not use the medicine after this date.

If you want more information about APO-TICAGRELOR:

  • Talk to your healthcare professional.
  • Find the full product monograph that is prepared for healthcare professionals and includes the Patient Medication Information by visiting the Health Canada Drug Product Database website (https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/drug-product-database.html); the manufacturer’s website (http://www.apotex.ca/products), or by calling 1-800-667-4708.

Date of Authorization: 2026-07-10

* All other trademarks are the property of their respective owner(s).

About this document

Source: Health Canada – Drug Product Database (DPD) and product monographs · DIN (Drug Identification Number): 02482622

Found a mistake? Write to us via the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Drug information for Apo-Ticagrelor

Rx or OTC
Prescription (Rx)?
DIN 02482622, 02482630
Schedule(s) PRESCRIPTION
Active ingredient(s) Ticagrelor
Dosage form(s) Tablet
Route(s) of administration Oral
Drug class (WHO ATC)
  1. B Blood and blood forming organ drugs
    1. B01 Antithrombotic agents
      1. B01A Antithrombotic agents
        1. B01AC Platelet aggregation inhibitors excl. heparin
          1. B01AC24 Ticagrelor
Company APOTEX INC
Current status Marketed
Strengths and forms
DIN Strength Dosage form(s) Current status
02482622 60 MG Tablet Marketed December 22, 2022
02482630 90 MG Tablet Marketed December 14, 2022

Source: Health Canada – Drug Product Database (DPD) and product monographs, data as of November 12, 2026. Data from the Health Canada Drug Product Database, as published there. Not a substitute for the advice of a doctor or pharmacist.